Muc4 is required for activation of ErbB2 in signet ring carcinoma cell lines

Biochemical and Biophysical Research Communications

Volumn 355, Issue 1, 2007, Pages 200-203

  Yokoyama, Atsushi ^a   Shi, Bin Hai ^a   Kawai, Takayuki ^a   Konishi, Hiroaki ^a   Andoh, Ryota ^a   Tachikawa, Hiroyuki ^a   Ihara, Sayoko ^a   Fukui, Yasuhisa ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Adenocarcinomas; ErbB2; ErbB3; Muc4; PI 3 kinase

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; MUCIN 4; PHOSPHATIDYLINOSITOL 3 KINASE; SHORT HAIRPIN RNA;

ADENOCARCINOMA; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN SECRETION; SIGNET RING CARCINOMA;

ADENOCARCINOMA; CARCINOMA, SIGNET RING CELL; CELL DIFFERENTIATION; CELL LINE; CELL LINE, TUMOR; HUMANS; KIDNEY; MUCINS; PHOSPHORYLATION; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3; RECOMBINANT PROTEINS; RNA, NEOPLASM; TRANSFECTION;

EID: 33847035890     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.01.133     Document Type: Article

References (17)

1. Tahara E. Molecular mechanism of stomach carcinogenesis. J. Cancer Res. Clin. Oncol. 119 (1993) 265-272
2. Duane G.B., and Kanter M.H. Light and electron microscopic characteristics of signet-ring adenocarcinoma cells in serous effusions and their distinction from mesothelial cells. Acta Cytol. 29 (1985) 211-218
3. Kobayashi M., Nagata S., Iwasaki T., Yanagihara K., Saitoh I., Karouji Y., Ihara S., and Fukui Y. Dedifferentiation of adenocarcinomas by activation of phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. USA 96 (1999) 4874-4879
4. Kobayashi M., Iwamatsu A., Shinohara-Kanda A., Ihara S., and Fukui Y. Activation of ErbB3-PI3-kinase pathway is correlated with malignant phenotypes of adenocarcinomas. Oncogene (2003) 1294-1301
5. Klapper L.N., Kirschbaum M.H., Sela M., and Yarden Y. Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors. Adv. Cancer Res. 77 (2000) 25-79
6. Carraway K.L., Carvajal M.E., Li P., and Carraway C.A. ErbB2 and its ligand Muc4 (sialomucin complex) in rat lacrimal gland. Adv. Exp. Med. Biol. 506 (2002) 289-295
7. Sherblom A.P., Buck R.L., and Carraway K.L. Purification of the major sialoglycoproteins of 13762 MAT-B1 and MAT-C1 rat ascites mammary adenocarcinoma cells by density gradient centrifugation in cesium chloride and guanidine hydrochloride. J. Biol. Chem. 255 (1980) 783-790
8. Sheng Z.Q., Hull S.R., and Carraway K.L. Biosynthesis of the cell surface sialomucin complex of ascites 13762 rat mammary adenocarcinoma cells from a high molecular weight precursor. J. Biol. Chem. 265 (1990) 8505-8510
9. Hull S.R., Sheng Z., Vanderpuye O., David C., and Carraway K.L. Isolation and partial characterization of ascites sialoglycoprotein-2 of the cell surface sialomucin complex of 13762 rat mammary adenocarcinoma cells. Biochem. J. 265 (1990) 121-129
10. Carraway III K.L., Rossi E.A., Komatsu M., Price-Schiavi S.A., Huang D., Guy P.M., Carvajal M.E., Fregien N., Carraway C.A., and Carraway K.L. An intramembrane modulator of the ErbB2 receptor tyrosine kinase that potentiates neuregulin signaling. J. Biol. Chem. 274 (1999) 5263-5266
11. DuBridge R.B., Tang P., Hsia H.C., Leong P.M., Miller J.H., and Calos M.P. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell Biol. 7 (1987) 379-387
12. Morita S., Kojima T., and Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene. Ther. 7 (2000) 1063-1066
13. Oka T., Ihara S., and Fukui Y. Cooperation of DEF6 with activated Rac in regulating cell morphology. J. Biol. Chem. 282 (2007) 2011-2018
14. Glenney Jr. J.R., and Zokas L. Novel tyrosine kinase substrates from Rous sarcoma virus-transformed cells are present in the membrane skeleton. J. Cell Biol. 108 (1989) 2401-2408
15. Nishikawa A., Uotsu N., Arimitsu H., Lee J.C., Miura Y., Fujinaga Y., Nakada H., Watanabe T., Ohyama T., Sakano Y., and Oguma K. The receptor and transporter for internalization of Clostridium botulinum type C progenitor toxin into HT-29 cells. Biochem. Biophys. Res. Commun. 319 (2004) 327-333
16. Shi B.H., Nashimoto T., Andoh R., Konishi H., Kobayashi M., Xu Q., Ihara S., and Fukui Y. Mutation of the PI3′ kinase gene in a human colon carcinoma cell line, HCC2998. DNA Cell Biol. 25 (2006) 399-405
17. Yaguchi S., Fukui Y., Koshimizu I., Yoshimi H., Matsuno T., Gouda H., Hirono S., Yamazaki K., and Yamori T. Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor. J. Natl. Cancer Inst. 98 (2006) 545-556